* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lee's Pharmaceutical Holdings OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Lee's Pharmaceutical Holdings's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lee's Pharmaceutical Holdings (FRA:L1PA) has a OCF Margin % of 20.05% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Lee's Pharmaceutical Holdings and its competitors. This is 13% below median its historical median of 23.09. Over the past decade, Lee's Pharmaceutical Holdings' OCF Margin % has ranged from 10.45 to 42.43. According to the industry distribution chart, Lee's Pharmaceutical Holdings ranks #158 out of 956 companies in the Drug Manufacturers industry, placing it in the top 16.5%.
Is Lee's Pharmaceutical Holdings' OCF Margin % too high?
Lee's Pharmaceutical Holdings' current OCF Margin % of 20.05% is 13% below median its 10-year median of 23.09. Over the past 10 years, this metric has ranged from a low of 10.45 to a high of 42.43. The Drug Manufacturers industry median OCF Margin % is 9.99. Lee's Pharmaceutical Holdings' value of 20.05% is 100.8% above this industry median. Based on the distribution chart, Lee's Pharmaceutical Holdings ranks #158 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Lee's Pharmaceutical Holdings has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Lee's Pharmaceutical Holdings' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Lee's Pharmaceutical Holdings ranks #158 out of 956 companies for OCF Margin %. This places Lee's Pharmaceutical Holdings in the top 17% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.99. Lee's Pharmaceutical Holdings' value of 20.05% is 100.8% above this benchmark. Historically, Lee's Pharmaceutical Holdings' own OCF Margin % has ranged from 10.45 to 42.43 over the past decade. While the company's 10-year median is 23.09 vs. the industry median of 9.99, Lee's Pharmaceutical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lee's Pharmaceutical Holdings's current OCF Margin % of 20.05% is 100.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Lee's Pharmaceutical Holdings and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lee's Pharmaceutical Holdings's current OCF Margin % is 20.05%, which is 13% below median its own 10-year median of 23.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lee's Pharmaceutical Holdings stock overvalued right now?
Lee's Pharmaceutical Holdings (FRA:L1PA) has a current OCF Margin % of 20.05%. The stock's GF Value™ is €0.17, compared to a current price of €0.11 — trading 37.1% below its estimated fair value. The current OCF Margin % is 20.05%, which is 13% below median its 10-year median of 23.09 and 100.8% above the Drug Manufacturers industry median of 9.99. Lee's Pharmaceutical Holdings' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Lee's Pharmaceutical Holdings (FRA:L1PA), the current OCF Margin % is 20.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lee's Pharmaceutical Holdings (FRA:L1PA) Overvalued in 2026?
Based on GuruFocus' analysis, Lee's Pharmaceutical Holdings stock appears to be undervalued.
The current stock price of €0.11 is trading 37.1% below its estimated GF Value™ of €0.17.
Key valuation signals for FRA:L1PA:
OCF Margin %: 20.05% (13% below median its 10-year median of 23.09)
GF Value™: €0.17 vs. price of €0.11 (37.1% below fair value)
Industry Position: 100.8% above the Drug Manufacturers median (#158 of 956)
No single metric tells the full story. See the FRA:L1PA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lee's Pharmaceutical Holdings Business Description
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue; and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.
74GF Score
Get the complete analysis for FRA:L1PA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L1PA has been successfully added to your 
